BVNRY BAVARIAN NORDIC

$9.54

BAVARIAN NORDIC (BVNRY) is expected to report earnings on August 28, 2026, before the market open.

BAVARIAN NORDIC Reported Earnings
Wednesday, May 13, 2026 · 12:00 AM ET
Earnings Date
Aug 28
Friday · Before Open
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About BAVARIAN NORDIC

Bavarian Nordic A/S is a biotechnology company. It focused on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases. The company's product pipeline consists of IMVAMUNE(R), PROSTVAC (R), MVA-BN Brachyury, CV-301, MVA-BN Filo which are in clinical trial stage. Bavarian Nordic A/S is headquartered in Kvistgaard, Denmark.

Sector

Healthcare